Ardian has acquired a significant minority stake in Aprium Pharmacie to support its ambitious growth plan. This investment aims to ensure the continued development of its service and consulting offerings, the expansion of its digital tools and training programs, and the ongoing development of its brand.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.